Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, will participate in two upcoming healthcare conferences.
Tuesday, March 7th at 10:30am ET/7:30am PT, the Company will take part in a corporate panel discussion on autoimmune and inflammatory diseases and host investor meetings at the 46th Annual Cowen Healthcare Conference
Tuesday, March 14th at 3:20pm ET/12:20 pm PT, the Company will participate in a fireside chat and host investor meetings at the 33rd Annual Oppenheimer Healthcare Conference.
Live webcasts of the presentations will be available in the investor relations section of the Company's website at https://ir.alpineimmunesciences.com/events and replays will be available on the Company's website for 90 days following the live events.
About Alpine Immune Sciences
Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients' lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com and follow us on Twitter and LinkedIn.
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...
Late yesterday the United States District Court for the Northern California ruled that CVS acted intentionally under the "deliberate indifference" standard when it implemented a drug program that discriminates against people living with HIV....
Alameda Health System needs help identifying a patient who arrived at the Wilma Chan Highland Hospital Campus on March 15, 2024, without identification....
Vayiz, an exciting new startup in innovative AI-driven medical imaging solutions, today announced the launch of its groundbreaking product, PTLC - Mark 1. This advanced medical diagnosis software utilizes state-of-the-art artificial intelligence to...
The Flowery, the leading name in the Florida medical cannabis industry renowned for its commitment to the highest quality and authentic experiences, proudly announces its unique collaboration with Udonis Haslem, a 3-time NBA Champion and legendary...
American Skin Association (ASA) is thrilled to announce that it has received Candid's eminent 2024 Platinum Seal of Transparency and the coveted Four-Star Rating from Charity Navigator. Candid (formerly Guidestar & Foundation Center) is the world's...